Potential Medication Safety Issues with Paxlovid

ISMP has alerted pharmacists about the need to remove extra tablets from the Paxlovid blister pack (a newly authorized COVID treatment), for patients with moderate renal impairment.

A Safer World by Preventing Medication Errors

For over 30 years, ISMP has been a global leader in patient safety. We are the first non-profit organization dedicated to the promotion of safe medication practices. Research, education, and advocacy are the foundation of everything we do, and our strong collaborative relationships have enabled us to help protect millions of patients.

Stay Connected.

Get medication safety news, event invitations and updates straight to your inbox!